Women with twin pregnancies should not be given prophylactic cerclage simply because they are carrying two fetuses. A 14-year retrospective study of twins using data from Matria Healthcare indicates that prophylactic cerclage is associated with a higher frequency of very premature delivery, low birth weight and very low birth weight infants, and more nursery days
Women with twin pregnancies should not be given prophylactic cerclage simply because they are carrying two fetuses. A 14-year retrospective study of twins using data from Matria Healthcare indicates that prophylactic cerclage is associated with a higher frequency of very premature delivery, low birth weight and very low birth weight infants, and more nursery days.
Andrei Rebarber, MD, and a team from NYU University Hospital in New York City combed the Matria Healthcare records of outpatient preterm labor surveillance between 1990 and 2004. The group compared twin pregnancies with and without prophylactic cerclage. Women with previous preterm deliveries or a diagnosis of cervical incompetence in a previous or the index pregnancy were excluded.
Of the 8,168 twin pregnancies that met inclusion criteria, 146, or 1.8%, received prophylactic cerclage. The incidence of delivery before 32 weeks was 19.2% in the prophylactic cerclage group compared to 12.1% in the non-cerclage group (P=0.014). Median birth weights were lower, 2,140 g compared to 2,310 g (P=0.001) for those without a cerclage. The cerclage group had 13.7 nursery days versus 11.7 days for the noncerclage group (P=0.012). Citing the risks involved, researches recommended against the use of prophylactic cerclage for the sole indication of twin pregnancy.
Rebarber R, Roman A, Saltzman D, Laughon SK, Rhea D. Prophylactic cerclage in the management of twin pregnancies. Obstet Gynecol. 2005;105(4 suppl):114S.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More